Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome
Fabio Di Domenico, Antonella Tramutola, Eugenio Barone, et al.
Redox Biology (2019) Vol. 23, pp. 101162-101162
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease
D. Allan Butterfield, Mark P. Mattson
Neurobiology of Disease (2020) Vol. 138, pp. 104795-104795
Open Access | Times Cited: 142
Chronic Stress and Oxidative Stress as Common Factors of the Pathogenesis of Depression and Alzheimer’s Disease: The Role of Antioxidants in Prevention and Treatment
Gabriela Juszczyk, Joanna Mikulska, Kamila Kasperek, et al.
Antioxidants (2021) Vol. 10, Iss. 9, pp. 1439-1439
Open Access | Times Cited: 122
Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease
Marzia Perluigi, Fabio Di Domenico, D. Allan Butterfield
Physiological Reviews (2023) Vol. 104, Iss. 1, pp. 103-197
Closed Access | Times Cited: 75
Mitochondrial dysfunction and neurological disorders: A narrative review and treatment overview
Eman E. Alshial, Muhammad Idris Abdulghaney, Al-Hassan Soliman Wadan, et al.
Life Sciences (2023) Vol. 334, pp. 122257-122257
Closed Access | Times Cited: 48
The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease
Eugenio Barone, Fabio Di Domenico, Marzia Perluigi, et al.
Free Radical Biology and Medicine (2021) Vol. 176, pp. 16-33
Open Access | Times Cited: 99
mTOR in Alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder
Marzia Perluigi, Fabio Di Domenico, Eugenio Barone, et al.
Free Radical Biology and Medicine (2021) Vol. 169, pp. 382-396
Open Access | Times Cited: 92
Proteomics Study of Peripheral Blood Mononuclear Cells in Down Syndrome Children
Chiara Lanzillotta, Viviana Greco, Diletta Valentini, et al.
Antioxidants (2020) Vol. 9, Iss. 11, pp. 1112-1112
Open Access | Times Cited: 83
Altered Metabolism in Alzheimer Disease Brain: Role of Oxidative Stress
Nicole Rummel, D. Allan Butterfield
Antioxidants and Redox Signaling (2021) Vol. 36, Iss. 16-18, pp. 1289-1305
Open Access | Times Cited: 70
Neuroprotective Benefits of Rosmarinus officinalis and Its Bioactives against Alzheimer’s and Parkinson’s Diseases
Danai Kosmopoulou, Maria-Parthena Lafara, Theodora Adamantidi, et al.
Applied Sciences (2024) Vol. 14, Iss. 15, pp. 6417-6417
Open Access | Times Cited: 10
Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions
Mara Dierssen, Marta Fructuoso, Maria Martínez de Lagrán, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 68
Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives
Chiara Lanzillotta, Fabio Di Domenico, Marzia Perluigi, et al.
CNS Drugs (2019) Vol. 33, Iss. 10, pp. 957-969
Open Access | Times Cited: 62
Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome
Antonella Tramutola, Chiara Lanzillotta, Fabio Di Domenico, et al.
Neurobiology of Disease (2020) Vol. 137, pp. 104772-104772
Open Access | Times Cited: 59
Protein Lipoxidation: Basic Concepts and Emerging Roles
Álvaro Viedma-Poyatos, Patricia González-Jiménez, Ophélie Langlois, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 295-295
Open Access | Times Cited: 42
The role of insulin/IGF1 signalling in neurodevelopmental and neuropsychiatric disorders – Evidence from human neuronal cell models
János Réthelyi, Katalin Vincze, Dorothea Schall, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 153, pp. 105330-105330
Open Access | Times Cited: 19
Shaping down syndrome brain cognitive and molecular changes due to aging using adult animals from the Ts66Yah murine model
Chiara Lanzillotta, Monika Rataj Baniowska, Francesca Prestia, et al.
Neurobiology of Disease (2024) Vol. 196, pp. 106523-106523
Open Access | Times Cited: 7
Intranasal Administration of KYCCSRK Peptide Rescues Brain Insulin Signaling Activation and Reduces Alzheimer’s Disease-like Neuropathology in a Mouse Model for Down Syndrome
Antonella Tramutola, Simona Lanzillotta, Giuseppe Aceto, et al.
Antioxidants (2023) Vol. 12, Iss. 1, pp. 111-111
Open Access | Times Cited: 15
Targeting increased levels of APP in Down syndrome: Posiphen‐mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model
Xu‐Qiao Chen, Ahmad Salehi, Matthew L. Pearn, et al.
Alzheimer s & Dementia (2020) Vol. 17, Iss. 2, pp. 271-292
Open Access | Times Cited: 39
Chronic PERK induction promotes Alzheimer-like neuropathology in Down syndrome: Insights for therapeutic intervention
Chiara Lanzillotta, Ilaria Zuliani, Antonella Tramutola, et al.
Progress in Neurobiology (2020) Vol. 196, pp. 101892-101892
Open Access | Times Cited: 33
The disturbance of protein synthesis/degradation homeostasis is a common trait of age-related neurodegenerative disorders
Fabio Di Domenico, Chiara Lanzillotta
Advances in protein chemistry and structural biology (2022), pp. 49-87
Closed Access | Times Cited: 19
Cellular senescence and premature aging in Down Syndrome
Lianli Peng, Alireza A. Baradar, Julio Aguado, et al.
Mechanisms of Ageing and Development (2023) Vol. 212, pp. 111824-111824
Closed Access | Times Cited: 12
Redox imbalance and metabolic defects in the context of Alzheimer disease
Fabio Di Domenico, Chiara Lanzillotta, Marzia Perluigi
FEBS Letters (2024)
Open Access | Times Cited: 4
Proteostasis Decline and Redox Imbalance in Age-Related Diseases: The Therapeutic Potential of NRF2
Brigitta Buttari, Antonella Tramutola, Ana I. Rojo, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 113-113
Open Access
Mitochondrial Imbalance in Down Syndrome: A Driver of Accelerated Brain Aging?
Xinxin Zuo
Aging and Disease (2025)
Open Access
Targeting Mitochondrial Network Architecture in Down Syndrome and Aging
Nunzia Mollo, Rita Cicatiello, Miriam Aurilia, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3134-3134
Open Access | Times Cited: 32
Antioxidants in Down Syndrome: From Preclinical Studies to Clinical Trials
Noemí Rueda Revilla, Carmen Martı́nez-Cué
Antioxidants (2020) Vol. 9, Iss. 8, pp. 692-692
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top